{"transactions":[{"id":4636202,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-10-06T20:34:56.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":79,"price":3.57,"value":282.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64449,"source":{"system":"sec-edgar","filing":"0001983944-26-000014","document":"form4-10062026_081052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1983944/000198394426000014/form4-10062026_081052.xml","form_type":"4"}},{"id":4636201,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-10-06T20:34:56.000Z","date":"2026-10-02","kind":"sale","planned":false,"acquired":false,"shares":893,"price":3.47,"value":3098.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.525 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64528,"source":{"system":"sec-edgar","filing":"0001983944-26-000014","document":"form4-10062026_081052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1983944/000198394426000014/form4-10062026_081052.xml","form_type":"4"}},{"id":706326,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-17T20:15:13.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on July 15, 2027 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":4.21,"expiration_date":"2036-07-15","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001983944-26-000010","document":"form4-07172026_040708.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000010/form4-07172026_040708.xml","form_type":"4"}},{"id":713345,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-07T21:00:10.000Z","date":"2026-07-06","kind":"sale","planned":false,"acquired":false,"shares":104,"price":4.31,"value":448.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.31 inclusive."}],"balance_after":64441,"source":{"system":"sec-edgar","filing":"0001983944-26-000008","document":"form4-07072026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000008/form4-07072026_050702.xml","form_type":"4"}},{"id":713344,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-07T21:00:10.000Z","date":"2026-07-02","kind":"sale","planned":false,"acquired":false,"shares":819,"price":4.27,"value":3497.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":64545,"source":{"system":"sec-edgar","filing":"0001983944-26-000008","document":"form4-07072026_050702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000008/form4-07072026_050702.xml","form_type":"4"}},{"id":814132,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-06T22:30:12.000Z","date":"2026-04-06","kind":"sale","planned":false,"acquired":false,"shares":102,"price":5.05,"value":515.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."}],"balance_after":65364,"source":{"system":"sec-edgar","filing":"0001983944-26-000006","document":"form4-04062026_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000006/form4-04062026_060407.xml","form_type":"4"}},{"id":814131,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-06T22:30:12.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":799,"price":4.91,"value":3923.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.88 to $4.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":65466,"source":{"system":"sec-edgar","filing":"0001983944-26-000006","document":"form4-04062026_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000006/form4-04062026_060407.xml","form_type":"4"}},{"id":918931,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T00:01:39.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":58000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on February 3, 2027 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":58000,"derivative":{"exercise_price":6.49,"expiration_date":"2036-02-03","underlying":"Ordinary Shares","underlying_shares":58000},"source":{"system":"sec-edgar","filing":"0001983944-26-000004","document":"form4-02052026_120235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000004/form4-02052026_120235.xml","form_type":"4"}},{"id":945567,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-07T01:00:40.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":75000,"derivative":{"exercise_price":7.08,"expiration_date":"2036-01-02","underlying":"Ordinary Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001983944-26-000002","document":"form4-01062026_080126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000002/form4-01062026_080126.xml","form_type":"4"}},{"id":945566,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:40.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":1115,"price":6.45,"value":7191.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.70 inclusive."}],"balance_after":66265,"source":{"system":"sec-edgar","filing":"0001983944-26-000002","document":"form4-01062026_080126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000002/form4-01062026_080126.xml","form_type":"4"}},{"id":945565,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:40.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":1317,"price":6.8,"value":8955.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5)."}],"balance_after":67380,"source":{"system":"sec-edgar","filing":"0001983944-26-000002","document":"form4-01062026_080126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000002/form4-01062026_080126.xml","form_type":"4"}},{"id":945564,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:40.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":68697,"source":{"system":"sec-edgar","filing":"0001983944-26-000002","document":"form4-01062026_080126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394426000002/form4-01062026_080126.xml","form_type":"4"}},{"id":1022797,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-10-06T20:45:06.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":103,"price":8.41,"value":866.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.40 to $8.50 inclusive."}],"balance_after":31197,"source":{"system":"sec-edgar","filing":"0001983944-25-000003","document":"form4-10062025_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394425000003/form4-10062025_041003.xml","form_type":"4"}},{"id":1022796,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-10-06T20:45:06.000Z","date":"2025-10-02","kind":"sale","planned":false,"acquired":false,"shares":221,"price":8.4,"value":1856.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":31300,"source":{"system":"sec-edgar","filing":"0001983944-25-000003","document":"form4-10062025_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000198394425000003/form4-10062025_041003.xml","form_type":"4"}},{"id":1091060,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-07T21:20:06.000Z","date":"2025-07-03","kind":"sale","planned":false,"acquired":false,"shares":100,"price":7.44,"value":744.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.405 to $7.483 inclusive."}],"balance_after":31521,"source":{"system":"sec-edgar","filing":"0001415889-25-019424","document":"form4-07072025_050703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925019424/form4-07072025_050703.xml","form_type":"4"}},{"id":1091059,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-07T21:20:06.000Z","date":"2025-07-02","kind":"sale","planned":false,"acquired":false,"shares":206,"price":7.09,"value":1460.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.09 to $7.14 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":31621,"source":{"system":"sec-edgar","filing":"0001415889-25-019424","document":"form4-07072025_050703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925019424/form4-07072025_050703.xml","form_type":"4"}},{"id":1177348,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-04-04T21:35:04.000Z","date":"2025-04-03","kind":"sale","planned":false,"acquired":false,"shares":109,"price":7.48,"value":815.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.45 to $7.50 inclusive."}],"balance_after":31827,"source":{"system":"sec-edgar","filing":"0001415889-25-010240","document":"form4-04042025_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925010240/form4-04042025_050401.xml","form_type":"4"}},{"id":1177347,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-04-04T21:35:04.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":210,"price":8.02,"value":1684.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":31936,"source":{"system":"sec-edgar","filing":"0001415889-25-010240","document":"form4-04042025_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925010240/form4-04042025_050401.xml","form_type":"4"}},{"id":1309596,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-07T00:30:31.000Z","date":"2025-01-02","kind":"grant","planned":true,"acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2026 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":43500,"derivative":{"exercise_price":14,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001415889-25-000928","document":"form4-01062025_070128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000928/form4-01062025_070128.xml","form_type":"4"}},{"id":1309595,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:31.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":2686,"price":15,"value":40290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."}],"balance_after":32146,"source":{"system":"sec-edgar","filing":"0001415889-25-000928","document":"form4-01062025_070128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000928/form4-01062025_070128.xml","form_type":"4"}},{"id":1309594,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:31.000Z","date":"2025-01-03","kind":"sale","planned":true,"acquired":false,"shares":159,"price":14.75,"value":2345.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.69 to $14.75 inclusive."}],"balance_after":34832,"source":{"system":"sec-edgar","filing":"0001415889-25-000928","document":"form4-01062025_070128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000928/form4-01062025_070128.xml","form_type":"4"}},{"id":1309593,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:31.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":1750,"price":14.09,"value":24657.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5)."}],"balance_after":34991,"source":{"system":"sec-edgar","filing":"0001415889-25-000928","document":"form4-01062025_070128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000928/form4-01062025_070128.xml","form_type":"4"}},{"id":1309592,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:31.000Z","date":"2025-01-02","kind":"grant","planned":true,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2026 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":36741,"source":{"system":"sec-edgar","filing":"0001415889-25-000928","document":"form4-01062025_070128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588925000928/form4-01062025_070128.xml","form_type":"4"}},{"id":1366143,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":false,"shares":1109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested and exercisable."}],"balance_after":12954,"derivative":{"exercise_price":9.82,"expiration_date":"2029-04-24","underlying":"Ordinary Shares","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366142,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":false,"shares":154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested and exercisable."}],"balance_after":302,"derivative":{"exercise_price":8.21,"expiration_date":"2029-04-24","underlying":"Ordinary Shares","underlying_shares":154},"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366141,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":false,"shares":1312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested and exercisable."}],"balance_after":2617,"derivative":{"exercise_price":1.87,"expiration_date":"2028-09-17","underlying":"Ordinary Shares","underlying_shares":1312},"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366140,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":231,"price":24.82,"value":5733.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $24.825 inclusive."}],"balance_after":19241,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366139,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":209,"price":24.77,"value":5176.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.73 to $24.81 inclusive."}],"balance_after":19472,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366138,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":3241,"price":25.21,"value":81705.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."}],"balance_after":19681,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366137,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":1109,"price":25.05,"value":27780.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6)."}],"balance_after":22922,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366136,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":true,"shares":1109,"price":9.82,"value":10890.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."}],"balance_after":24031,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366135,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":154,"price":25.01,"value":3851.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.08 inclusive."}],"balance_after":22922,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366134,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":true,"shares":154,"price":8.21,"value":1264.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024."}],"balance_after":23076,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366133,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":1312,"price":25.05,"value":32865.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6)."}],"balance_after":22922,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1366132,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-14T00:43:02.000Z","date":"2024-11-11","kind":"exercise","planned":true,"acquired":true,"shares":1312,"price":1.87,"value":2453.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024."}],"balance_after":24234,"source":{"system":"sec-edgar","filing":"0001415889-24-026758","document":"form4-11142024_121158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924026758/form4-11142024_121158.xml","form_type":"4"}},{"id":1390593,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-10-04T20:50:05.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":153,"price":22.26,"value":3405.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.91 to $22.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22922,"source":{"system":"sec-edgar","filing":"0001415889-24-024767","document":"form4-10042024_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924024767/form4-10042024_041001.xml","form_type":"4"}},{"id":1458107,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-07-08T22:55:12.000Z","date":"2024-07-03","kind":"sale","planned":false,"acquired":false,"shares":148,"price":19.64,"value":2906.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23075,"source":{"system":"sec-edgar","filing":"0001415889-24-019387","document":"form4-07082024_060709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924019387/form4-07082024_060709.xml","form_type":"4"}},{"id":1546385,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-04-05T20:30:34.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":152,"price":23.81,"value":3619.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.75 to $24.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23223,"source":{"system":"sec-edgar","filing":"0001415889-24-010413","document":"form4-04052024_040425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000141588924010413/form4-04052024_040425.xml","form_type":"4"}},{"id":1686844,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-04T23:36:15.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":31000,"derivative":{"exercise_price":18.08,"expiration_date":"2034-01-02","underlying":"Ordinary Shares","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001209191-24-000890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919124000890/doc4.xml","form_type":"4"}},{"id":1686843,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-01-04T23:36:15.000Z","date":"2024-01-03","kind":"sale","planned":false,"acquired":false,"shares":604,"price":17.5,"value":10570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.07 to $18.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23375,"source":{"system":"sec-edgar","filing":"0001209191-24-000890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919124000890/doc4.xml","form_type":"4"}},{"id":1686842,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2024-01-04T23:36:15.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":23979,"source":{"system":"sec-edgar","filing":"0001209191-24-000890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919124000890/doc4.xml","form_type":"4"}},{"id":1764185,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-10-05T21:50:32.000Z","date":"2023-10-03","kind":"sale","planned":false,"acquired":false,"shares":54,"price":20,"value":1080.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7979,"source":{"system":"sec-edgar","filing":"0001209191-23-052254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123052254/doc4.xml","form_type":"4"}},{"id":1833451,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":29666,"kind":"person","name":"Thompson Travis Alvin","position":1,"cik":"0001983944","reported_name":"Thompson Travis Alvin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2023-07-06T20:57:30.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":61,"price":25.1,"value":1531.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8033,"source":{"system":"sec-edgar","filing":"0001209191-23-041578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761612/000120919123041578/doc4.xml","form_type":"4"}}]}